We are live on ! Find out more
KIN

Kindred Biosciences
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

60 hedge funds and large institutions have $84.2M invested in Kindred Biosciences in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.55% less ownership

Funds ownership: 60.38% → 59.82% (-0.55%)

6% less funds holding

Funds holding: 64 → 60 (-4)

18% less capital inflows, than outflows

Capital inflows: $3.97M | Capital outflows: $4.85M

22% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 23

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
60
Holders Change
-4
Holders Change %
-6.25%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
18
Reduced
23
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KIN Hedge Fund Activity: Q1 2015 in Review

60 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences (KIN) for Q1 2015, worth a combined $84.2M — down 5% from $88.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of KIN and 4 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 18 added.

The largest buyer was Ariel Investments, adding an estimated $1.03M. The largest seller was AWM Investment Company, exiting entirely with an estimated $977K sold.

  • 60 institutional investors held Kindred Biosciences (KIN) as of Q1 2015, down from 64 in Q4 2014.
  • Funds reported $84.2M of Kindred Biosciences stock for Q1 2015, down 5% quarter-over-quarter.
  • 4 funds opened new Kindred Biosciences positions in Q1 2015 and 8 closed out, a net change of -4 holders.
  • The largest Kindred Biosciences buyer in Q1 2015 was Ariel Investments, an estimated $1.03M added.
  • The largest Kindred Biosciences seller in Q1 2015 was AWM Investment Company, an estimated $977K sold.

Based on aggregated 13F filings for Q1 2015.